Numerai’s DexCom DXCM Stock Holding History

Numerai’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,548	Closed	-$841K	–	424
2024 Q3	$841K	Buy	+12,548	New	+$1.03M	0.22%	155
2024 Q2	–	Sell	-1,485	Closed	-$206K	–	354
2024 Q1	$206K	Buy	+1,485	New	+$187K	0.09%	227

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Numerai's DXCM Position: Q4 2024 in Review

Numerai sold out of DexCom (DXCM) in Q4 2024, closing a stake of 12,548 shares — an estimated $841K sold.

Numerai first reported a position in DXCM in Q1 2024 and held it in 2 quarters. The position peaked at $841K in Q3 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

Numerai reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
Numerai sold 12,548 DexCom shares in Q4 2024, an estimated $841K.
Numerai first reported a position in DexCom in Q1 2024 and held it in 2 quarters.
Numerai's DexCom position peaked at $841K in Q3 2024.
950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Numerai's 13F filing for Q4 2024, filed 14 Feb 2025.